Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 49 hits in this display
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
IC50: 8.65E+3nMAssay Description:In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
IC50: >1.00E+4nMAssay Description:In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
IC50: 1.09E+4nMAssay Description:In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptorMore data for this Ligand-Target Pair
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133232((S)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133230((R)-1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]in...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)
BDBM50133229(1-Methyl-2-(3,7,8,9-tetrahydro-pyrano[3,2-e]indol-...)